Beware Basing Your MedTech Pricing on Short-term New Tech Payment Mechanisms
Published on: 04/03/2025
New tech payments like NTAP can’t justify long-term pricing. Here’s what MedTech founders need to know.
U.S. Healthcare Fundamentals
New tech payments like NTAP can’t justify long-term pricing. Here’s what MedTech founders need to know.
Why do better technologies struggle for reimbursement while outdated ones thrive? Discover the hidden bias in payer decision-making—and why second movers in MedTech face steeper evidence hurdles than the first.
In MedTech reimbursement, no news can be good news. Learn how to reduce payer confusion and build clarity into your strategy.
This 9-question quiz helps medtech founders assess if they're ready to tackle reimbursement.